Hanemann CO - Search Results

1

Fludeoxyglucose F 18 positron emission tomography and computed tomography of a giant retroperitoneal schwannoma occurring in a patient with neurofibromatosis type 2.

Hanemann CO, Kaempchen KE, Kaufmann D, Krause BJ. Hanemann CO, et al. Arch Neurol. 2005 Apr;62(4):674-5. doi: 10.1001/archneur.62.4.674. Arch Neurol. 2005. PMID: 15824272 No abstract available.

2

Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene.

Kaufmann D, Müller R, Bartelt B, Wolf M, Kunzi-Rapp K, Hanemann CO, Fahsold R, Hein C, Vogel W, Assum G. Kaufmann D, et al. Among authors: hanemann co. Am J Hum Genet. 2001 Dec;69(6):1395-400. doi: 10.1086/324648. Epub 2001 Oct 18. Am J Hum Genet. 2001. PMID: 11704931 Free PMC article.

3

Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2.

Sperfeld AD, Hein C, Schröder JM, Ludolph AC, Hanemann CO. Sperfeld AD, et al. Among authors: hanemann co. Brain. 2002 May;125(Pt 5):996-1004. doi: 10.1093/brain/awf115. Brain. 2002. PMID: 11960890

4

X-linked bulbospinal neuronopathy: Kennedy disease.

Sperfeld AD, Karitzky J, Brummer D, Schreiber H, Häussler J, Ludolph AC, Hanemann CO. Sperfeld AD, et al. Among authors: hanemann co. Arch Neurol. 2002 Dec;59(12):1921-6. doi: 10.1001/archneur.59.12.1921. Arch Neurol. 2002. PMID: 12470181

5

Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation.

Hanemann CO, Bergmann C, Senderek J, Zerres K, Sperfeld AD. Hanemann CO, et al. Arch Neurol. 2003 Apr;60(4):605-9. doi: 10.1001/archneur.60.4.605. Arch Neurol. 2003. PMID: 12707076

6

Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells.

Kaempchen K, Mielke K, Utermark T, Langmesser S, Hanemann CO. Kaempchen K, et al. Among authors: hanemann co. Hum Mol Genet. 2003 Jun 1;12(11):1211-21. doi: 10.1093/hmg/ddg146. Hum Mol Genet. 2003. PMID: 12761036

7

Pathological adhesion of primary human schwannoma cells is dependent on altered expression of integrins.

Utermark T, Kaempchen K, Hanemann CO. Utermark T, et al. Among authors: hanemann co. Brain Pathol. 2003 Jul;13(3):352-63. doi: 10.1111/j.1750-3639.2003.tb00034.x. Brain Pathol. 2003. PMID: 12946024 Free PMC article.

8

Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.

Diebold R, Bartelt-Kirbach B, Evans DG, Kaufmann D, Hanemann CO. Diebold R, et al. Among authors: hanemann co. J Mol Diagn. 2005 Feb;7(1):97-104. doi: 10.1016/S1525-1578(10)60014-1. J Mol Diagn. 2005. PMID: 15681480 Free PMC article.

9

Reduced apoptosis rates in human schwannomas.

Utermark T, Kaempchen K, Antoniadis G, Hanemann CO. Utermark T, et al. Among authors: hanemann co. Brain Pathol. 2005 Jan;15(1):17-22. doi: 10.1111/j.1750-3639.2005.tb00095.x. Brain Pathol. 2005. PMID: 15779232 Free PMC article.

10

Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD.

Münch C, Rosenbohm A, Sperfeld AD, Uttner I, Reske S, Krause BJ, Sedlmeier R, Meyer T, Hanemann CO, Stumm G, Ludolph AC. Münch C, et al. Among authors: hanemann co. Ann Neurol. 2005 Nov;58(5):777-80. doi: 10.1002/ana.20631. Ann Neurol. 2005. PMID: 16240349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page